Discover the Dr. Reddy's Laboratories Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis ...

Welcome to the Dr. Reddy's Laboratories Stock Liveblog, your ultimate source for real-time updates and analysis of one of the ...

Dr. Reddy's Laboratories Ltd. 500124 shares inched down 0.26% to 6,630.85 Indian rupees Tuesday, on what proved to be an ...

Dr. Reddy's Laboratories Ltd. 500124 shares inched down 0.38% to 6,658.60 Indian rupees Friday, on what proved to be an ...

MUMBAI (Reuters) -Indian automaker Mahindra & Mahindra and pharmaceutical company Dr Reddy's Laboratories said on Tuesday ...

In a stock filing, Dr Reddy’s Laboratories acknowledged payments to Dhaval Buch for coaching services but rejected conflict ...

HYDERABAD, India, August 20, 2024--Dr. Reddy’s Laboratories, Aurigene, and Kainomyx announce potential partnership for joint development of affordable anti-malarial drug. HYDERABAD, India, July 29, ...

Get the latest Business News, Live Share & Stock Market Updates, Top News from India and across world. Read Top Business News ...

Dismissing allegations of irregularities, three listed companies - Mahindra & Mahindra, Pidilite Industries and Dr Reddy's ...

L&T: L&T Semiconductor Technologies, a subsidiary of L&T, has entered into a strategic alliance with IBM to advance processor ...

Dr Reddy's Laboratories received a Voluntary Action Indicated (VAI) establishment inspection report (EIR) from the USFDA for its API facility in Srikakulam, Andhra Pradesh.

USFDA classifies Dr. Reddy's inspection as VAI, with no administrative or regulatory action recommended, shares down 0.42%.